Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $26.82 in the prior trading day, Universal Technical Institute Inc (NYSE: UTI) closed at $26.5, down -1.19%. In other words, the price has decreased by -$1.19 from its previous closing price. On the day, 0.56 million shares were traded. UTI stock price reached its highest trading level at $27.0699 during the session, while it also had its lowest trading level at $26.43.
Ratios:
Our goal is to gain a better understanding of UTI by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.96 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.30. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 1.00. In the meantime, Its Debt-to-Equity ratio is 0.85 whereas as Long-Term Debt/Eq ratio is at 0.78.
On July 25, 2024, Truist started tracking the stock assigning a Buy rating and target price of $22. On January 10, 2024, Northland Capital started tracking the stock assigning a Outperform rating and target price of $16.Northland Capital initiated its Outperform rating on January 10, 2024, with a $16 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 12 ’25 when DEVINCENZI ROBERT THOMAS bought 10,000 shares for $25.40 per share. The transaction valued at 253,991 led to the insider holds 136,765 shares of the business.
Coliseum Capital Management, L sold 500,000 shares of UTI for $17,500,000 on May 27 ’25. The Director now owns 2,716,267 shares after completing the transaction at $35.00 per share. On May 15 ’25, another insider, Hitchcock Todd A, who serves as the EVP/COO of the company, sold 27,500 shares for $33.36 each. As a result, the insider received 917,471 and left with 80,521 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UTI now has a Market Capitalization of 1442225408 and an Enterprise Value of 1584910720. As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.29, and their Forward P/E ratio for the next fiscal year is 26.42. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.23. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.78 while its Price-to-Book (P/B) ratio in mrq is 4.70. Its current Enterprise Value per Revenue stands at 1.958 whereas that against EBITDA is 13.567.
Stock Price History:
The Beta on a monthly basis for UTI is 1.65, which has changed by 0.53980243 over the last 52 weeks, in comparison to a change of 0.14460516 over the same period for the S&P500. Over the past 52 weeks, UTI has reached a high of $36.32, while it has fallen to a 52-week low of $15.14. The 50-Day Moving Average of the stock is -14.06%, while the 200-Day Moving Average is calculated to be -6.42%.
Shares Statistics:
The stock has traded on average 747.45K shares per day over the past 3-months and 910030 shares per day over the last 10 days, according to various share statistics. A total of 54.42M shares are outstanding, with a floating share count of 52.27M. Insiders hold about 3.96% of the company’s shares, while institutions hold 92.81% stake in the company. Shares short for UTI as of 1753920000 were 2384014 with a Short Ratio of 3.19, compared to 1751241600 on 2717608. Therefore, it implies a Short% of Shares Outstanding of 2384014 and a Short% of Float of 5.1599998000000005.
Earnings Estimates
As of right now, 6.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.24, with high estimates of $0.29 and low estimates of $0.17.
Analysts are recommending an EPS of between $1.11 and $1.02 for the fiscal current year, implying an average EPS of $1.06. EPS for the following year is $1.0, with 6.0 analysts recommending between $1.1 and $0.9.
Revenue Estimates
6 analysts predict $219.32M in revenue for the current quarter. It ranges from a high estimate of $220.6M to a low estimate of $216.8M. As of the current estimate, Universal Technical Institute Inc’s year-ago sales were $196.36MFor the next quarter, 6 analysts are estimating revenue of $219.6M. There is a high estimate of $226.71M for the next quarter, whereas the lowest estimate is $214.91M.
A total of 6 analysts have provided revenue estimates for UTI’s current fiscal year. The highest revenue estimate was $833.77M, while the lowest revenue estimate was $830M, resulting in an average revenue estimate of $832.49M. In the same quarter a year ago, actual revenue was $732.69MBased on 6 analysts’ estimates, the company’s revenue will be $906.69M in the next fiscal year. The high estimate is $930.21M and the low estimate is $900M.
